A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy
Primary Research
A deliverable presented to the client team dived into:
The client leveraged these findings to inform which new diagnostic assays to develop for the European market and ancillary capabilities to invest in to service the transitioning European market
5 weeks
Europe
Clinical Diagnostics
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy